Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma

doi:10.4240/wjgs.v17.i10.111454

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

This Article

(57)

(66)

(0)

(12)

(791)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Surg. Oct 27, 2025; 17(10): 111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454

Full Size Figure Download Figure

Figure 12 Alterations in epithelial-mesenchymal transition. A: Epithelial–mesenchymal transition (EMT)-related protein E-cadherin expression after overexpression plasmid transfection; B: EMT-related protein N-cadherin expression after overexpression plasmid transfection; C: EMT-related protein vimentin expression after overexpression plasmid transfection; D: E-cadherin expression after siRNA transfection; E: N-cadherin expression after siRNA transfection; F: Vimentin expression after siRNA transfection. EMT: Epithelial–mesenchymal transition. ^aP < 0.05, ^bP < 0.01.

Citation: Guo W, Wang MX, Mu T, Xu K, Jiang ZD, Wan XH, Li JW, Yi YX. Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 111454
URL: https://www.wjgnet.com/1948-9366/full/v17/i10/111454.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.111454

Guo W, Wang MX, Mu T, Xu K, Jiang ZD, Wan XH, Li JW, Yi YX. Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 111454 [PMID: 41178881 DOI: 10.4240/wjgs.v17.i10.111454]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.